<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_3ZGPtm2">Financial incentives promote many health behaviors, but effective ways to deliver health incentives remain uncertain</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">K</forename><forename type="middle">G V</forename><surname>Wharton</surname></persName>
						</author>
						<author role="corresp">
							<persName><roleName>Dr</roleName><surname>Halpern</surname></persName>
							<email>shalpern@exchange.upenn.edu</email>
						</author>
						<author>
							<persName><roleName>M.D</roleName><forename type="first">Scott</forename><forename type="middle">D</forename><surname>Halpern</surname></persName>
						</author>
						<author>
							<persName><roleName>Ph.D</roleName><forename type="first">Benjamin</forename><surname>French</surname></persName>
						</author>
						<author>
							<persName><roleName>Ph.D</roleName><forename type="first">Dylan</forename><forename type="middle">S</forename><surname>Small</surname></persName>
						</author>
						<author>
							<persName><roleName>Ph.D</roleName><forename type="first">Kathryn</forename><surname>Saulsgiver</surname></persName>
						</author>
						<author>
							<persName><roleName>Ph.D</roleName><forename type="first">Michael</forename><forename type="middle">O</forename><surname>Harhay</surname></persName>
						</author>
						<author>
							<persName><roleName>Ph.D</roleName><forename type="first">Janet</forename><surname>Audrain-Mcgovern</surname></persName>
						</author>
						<author>
							<persName><roleName>Ph.D</roleName><forename type="first">George</forename><surname>Loewenstein</surname></persName>
						</author>
						<author>
							<persName><roleName>M.D</roleName><forename type="first">Troyen</forename><forename type="middle">A</forename><surname>Brennan</surname></persName>
						</author>
						<author>
							<persName><roleName>J.D</roleName><forename type="first">David</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
						</author>
						<author>
							<persName><roleName>M.B</roleName><forename type="first">Kevin</forename><forename type="middle">A G</forename><surname>Volpp</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<note type="raw_affiliation">Perelman School of Medicine at the Uni- versity of Pennsylvania , the Departments of Statistics (D.S.S.) and Health Care Management School , University of Pennsylvania Cen- ter for Health Equity Research and Pro- motion , the Philadelphia Veterans Affairs Medical Center ( D.A.</note>
								<orgName type="department" key="dep1">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep2">Departments of Statistics (D.S.S.) and Health Care Management</orgName>
								<orgName type="department" key="dep3">School</orgName>
								<orgName type="institution" key="instit1">Uni- versity of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania Cen- ter for Health Equity Research and Pro- motion</orgName>
								<orgName type="institution" key="instit3">the Philadelphia Veterans Affairs Medical Center (</orgName>
								<address>
									<country>D.A</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<note type="raw_affiliation">Center for Health Care Innovation , Uni- versity of Pennsylvania Health System (D. Philadelphia ; the</note>
								<orgName type="department">Center for Health Care Innovation</orgName>
								<orgName type="institution">Uni- versity of Pennsylvania Health System (D</orgName>
								<address>
									<settlement>Philadelphia</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">Center for Behavioral Decision Research , Carnegie Mellon University , Pittsburgh Woonsocket , RI</note>
								<orgName type="department">Center for Behavioral Decision Research</orgName>
								<orgName type="institution">Carnegie Mellon University</orgName>
								<address>
									<settlement>Pittsburgh Woonsocket</settlement>
									<region>RI</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">Perelman School of Medicine , University of Pennsylvania , 719 Blockley Hall , 423 Guardian Dr. , Phila- delphia , PA 19104-6021 ,</note>
								<orgName type="department">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<addrLine>719 Blockley Hall 423 Guardian Dr.</addrLine>
									<postCode>19104-6021</postCode>
									<settlement>Phila- delphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_MgmCVAG">Financial incentives promote many health behaviors, but effective ways to deliver health incentives remain uncertain</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">A9B14022B6CFBED9F3DFD06C9411D15A</idno>
					<idno type="DOI">10.1056/nejmoa1414293</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T07:06+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_aEeWUNE">METHODS</head><p xml:id="_JC3tASy"><s xml:id="_4bBWBqC">We randomly assigned CVS Caremark employees and their relatives and friends to one of four incentive programs or to usual care for smoking cessation.</s><s xml:id="_UGAZKd8">Two of the incentive programs targeted individuals, and two targeted groups of six participants.</s><s xml:id="_DsYE3TF">One of the individual-oriented programs and one of the group-oriented programs entailed rewards of approximately $800 for smoking cessation; the others entailed refundable deposits of $150 plus $650 in reward payments for successful participants.</s><s xml:id="_KzCsypF">Usual care included informational resources and free smokingcessation aids.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vyYdsrE">RESULTS</head><p xml:id="_PK9AtAM"><s xml:id="_KT2kjZs">Overall, 2538 participants were enrolled.</s><s xml:id="_knjC8Fj">Of those assigned to reward-based programs, 90.0% accepted the assignment, as compared with 13.7% of those assigned to deposit-based programs (P&lt;0.001).</s><s xml:id="_ytgJjdz">In intention-to-treat analyses, rates of sustained abstinence from smoking through 6 months were higher with each of the four incentive programs (range, 9.4 to 16.0%) than with usual care (6.0%) (P&lt;0.05 for all comparisons); the superiority of reward-based programs was sustained through 12 months.</s><s xml:id="_73usAnb">Group-oriented and individual-oriented programs were associated with similar 6-month abstinence rates (13.7% and 12.1%, respectively; P = 0.29).</s><s xml:id="_RcBfgXS">Reward-based programs were associated with higher abstinence rates than deposit-based programs (15.7% vs. 10.2%,</s><s xml:id="_dGhzxCH">P&lt;0.001).</s><s xml:id="_QKBHRu5">However, in instrumental-variable analyses that accounted for differential acceptance, the rate of abstinence at 6 months was 13.2 percentage points (95% confidence interval, 3.1 to 22.8) higher in the deposit-based programs than in the reward-based programs among the estimated 13.7% of the participants who would accept participation in either type of program.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NGxSgd2">CONCLUSIONS</head><p xml:id="_PG37R6Q"><s xml:id="_Q7p4aUU">Reward-based programs were much more commonly accepted than deposit-based programs, leading to higher rates of sustained abstinence from smoking.</s><s xml:id="_NcRvhNp">Grouporiented incentive programs were no more effective than individual-oriented programs.</s><s xml:id="_Q3zVZWD">(Funded by the National Institutes of Health and CVS Caremark; ClinicalTrials.gov</s><s xml:id="_EY3f2Ud">number, NCT01526265.)</s></p><p xml:id="_bZUNm6T"><s xml:id="_3ZGknBe">A BS TR AC T Randomized Trial of Four Financial-Incentive Programs for Smoking Cessation F inancial incentives have been shown to promote a variety of health behaviors. <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref></s><s xml:id="_mXhZavb">]<ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref> For example, in a randomized, clinical trial involving 878 General Electric employees, a bundle of incentives worth $750 for smoking cessation nearly tripled quit rates, from 5.0% to 14.7%, <ref type="bibr" target="#b7">8</ref> and led to a program adapted by General Electric for its U.S. employees. <ref type="bibr" target="#b8">9</ref></s><s xml:id="_bH7bNqe">Although incentive programs are increasingly used by governments, employers, and insurers to motivate changes in health behavior, <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11</ref> their design is usually based on the traditional economic assumption that the size of the incentive determines its effectiveness.</s><s xml:id="_U6h4zjy">In contrast, behavioral economic theory suggests that incentives of similar size may have very different effects depending on how they are designed. <ref type="bibr" target="#b11">12</ref></s><s xml:id="_AwKrsH6">or example, deposit or "commitment" contracts, whereby participants put some of their own money at risk and recoup it if they are successful in changing their behavior, have been used in a variety of online and employer-based behavioral-change programs.</s><s xml:id="_amuFyy4">Because people are typically more motivated to avoid losses than to seek gains, <ref type="bibr" target="#b12">13</ref> deposit contracts should be more successful than reward programs.</s><s xml:id="_vNUakjm">However, the need to make deposits may deter people from participating, and the overall effectiveness of deposit and reward programs has not been compared. <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref></s><s xml:id="_XSkyAvy">urthermore, incentives that target groups may be more effective than incentives that target individuals because people are strongly motivated by social comparisons. <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref></s><s xml:id="_JZzgYqW">7]<ref type="bibr" target="#b17">[18]</ref> Collaborative incentives, whereby payments to successful group members increase with the overall success of the group, may add dimensions of interpersonal accountability and teamwork. <ref type="bibr" target="#b18">19</ref></s><s xml:id="_5kXDWwS">Competitive designs, such as pari-mutuel schemes in which money deposited by group members who do not change their behavior gets distributed to group members who do, may amplify peoples' aversions to loss by highlighting the regret they may feel if others benefit from their failure to change. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21</ref></s><s xml:id="_F2Xsy8u">e therefore evaluated incentive programs for smoking cessation that are based on rewards or deposit contracts and that are delivered at the individual or group level, comparing the interventions on three measures: acceptance, defined as the proportion of people who accept the incentive program when offered; overall effectiveness, assessed as the proportion of people offered each program who stop smoking; and efficacy, assessed as the proportion of people who stop smoking if they accept a given incentive program.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_medeXhU">Me thods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Tk8Sk7s">Trial Design</head><p xml:id="_GwyUgZ8"><s xml:id="_y5aeVSK">We conducted a five-group randomized, controlled trial comparing usual care with four incentive programs aimed at promoting sustained abstinence from smoking.</s><s xml:id="_WnQVzEx">The protocol (available with the full text of this article at NEJM.org) was approved by the institutional review board at the University of Pennsylvania.</s><s xml:id="_94ya6dS">The first author vouches for the accuracy and completeness of the data and for the fidelity of the study to the protocol.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_YYyuZF3">Study Population</head><p xml:id="_uN7Hmun"><s xml:id="_fzZX428">We used a multifaceted recruitment scheme (Fig. <ref type="figure" target="#fig_0">S1</ref> in the Supplementary Appendix, available at NEJM.org) to enroll CVS Caremark employees or their relatives and friends across the United States.</s><s xml:id="_Q2s5wFB">Eligible participants were at least 18 years of age, reported smoking at least 5 cigarettes per day, had Internet access, and indicated an interest in learning about ways to stop smoking.</s><s xml:id="_95buDfa">Recruitment occurred from February 2012 through October 2012.</s><s xml:id="_mAg245r">Using the Way to Health Web-based research portal created for this and other studies, <ref type="bibr" target="#b21">22</ref> participants opened an account, electronically signed the informedconsent document, and completed a baseline questionnaire.</s><s xml:id="_trcvesZ">Participants were told that they would be paid for completing questionnaires and submitting samples to confirm smoking abstinence and that the study tested different ways of providing financial incentives to promote cessation.</s><s xml:id="_5M7XC7D">To dissuade nonsmokers from enrolling, we also informed potential participants that we would randomly screen for baseline smoking.</s></p><p xml:id="_KtTxrXF"><s xml:id="_7MehEp3">After randomization, participants learned the details of their assigned intervention, were asked to accept or decline their intervention, and chose a target quit date between 1 and 90 days after enrollment.</s><s xml:id="_6ujnndG">We then selected a random sample of 5% of these enrolled participants to undergo baseline cotinine screening and offered $100 for completing a cotinine assay.</s></p><p xml:id="_mqgP8MA"><s xml:id="_cymXx27">Participants were randomly assigned on an individual basis to one of five groups (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_esMbFYx">Randomization was stratified according to two dichotomous variables: whether participants had full health care benefits through CVS Caremark and whether their annual household income was at least $60,000 (the CVS Caremark workforce median) or less than $60,000.</s><s xml:id="_DdHBbzc">We developed an adaptive randomization algorithm <ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref> that updated the assignment probabilities to the five groups after every third enrolled participant.</s><s xml:id="_sh6ngar">Updated probabilities reflected the inverse of the proportion of participants assigned to that group who accepted the intervention, relative to total acceptance across groups. <ref type="bibr" target="#b25">26</ref></s><s xml:id="_fNuQsVs">This approach balances recruitment of accepting participants across groups by increasing the odds of randomization to interventions that previous participants declined.</s></p><p xml:id="_yT8ngxe"><s xml:id="_VSpDSDF">All the participants were offered usual care, consisting of information about local smokingcessation resources, cessation guides produced by the American Cancer Society, and, for the 41% of the participants receiving health benefits through CVS Caremark, free access to a behavioral-modification program and nicotine-replacement therapy.</s><s xml:id="_jRpPbAr">Participants assigned to the two individual-incentive groups were also eligible to receive $200 if they had biochemically confirmed abstinence at each of three times: 14 days, 30 days, and 6 months after their target quit dates.</s><s xml:id="_krsSqXq">Participants would get an additional $200 bonus at 6 months, for a total of $800 (Fig. <ref type="figure" target="#fig_3">S2</ref> in the Supplementary Appendix).</s><s xml:id="_rZwyrPx">In the individual-deposit group, this sum included a $150 deposit that would be refunded to participants who quit smoking.</s></p><p xml:id="_BQczYcY"><s xml:id="_QngbyY8">In the collaborative-reward and competitivedeposit groups, cohorts of six smokers each were formed on a rolling basis, linking participants 2538 Underwent randomization 4629 Persons created Way to Health account 612 Were excluded 10 Were &lt;18 yr of age 84 Smoked &lt;5 cigarettes/day 54 Smoked &lt;6 mo 38 Did not have Internet access 426 Were not CVS Caremark employees or their relatives or friends 4017 Were eligible 1479 Did not complete enrollment 52 Did not provide consent 55 Would not give Social Security number 1372 Did not complete baseline survey 468 Were assigned to usual care 468 Were included in primary analysis 471 Were assigned to competitive deposit 471 Were included in primary analysis 582 Were assigned to individual deposit 582 Were included in primary analysis 519 Were assigned to collaborative reward 519 Were included in primary analysis 498 Were assigned to individual reward 498 Were included in primary analysis The New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.</s><s xml:id="_a7V7puZ">Downloaded from nejm.org at University of Iowa--Iowa City on July 28, 2025.</s><s xml:id="_j5uaecQ">Copyright © 2015 Massachusetts Medical Society.</s><s xml:id="_zdYQUsa">All rights reserved, including those for text and data mining, AI training, and similar technologies.</s></p><p xml:id="_82TPCqR"><s xml:id="_AwSsCDT">Financial-Incentive Progr ams for Smoking Cessation who selected quit dates nearest each other.</s><s xml:id="_SPBJf4x">In the collaborative-reward group, payments to successful group members at each time point increased with increasing group success rates, from $100 per time point if one participant quit to $600 per time point per participant if all six quit.</s><s xml:id="_MWqTgnj">We sought to foster collaboration among participants with the use of a Web-based chat room through which they could communicate throughout the study.</s></p><p xml:id="_NS5FvkC"><s xml:id="_qaUzxzD">In the competitive-deposit group, $150 deposits from each of six group members, plus a $450 matching reward per member ($3,600 total), was redistributed among members who quit at each time point.</s><s xml:id="_XUm3MDK">For example, if only two participants in a group quit at 14 days but returned to smoking by 30 days, those two participants would receive $600 each at 14 days, and there would be no further payouts to the members of that group.</s><s xml:id="_B2chqqg">Members of competitive cohorts received accurate but anonymous descriptions of their competitors to make vivid the possibility that others might benefit from their own lack of change <ref type="bibr" target="#b20">21</ref> without enabling participants to undermine a competitor's efforts.</s></p><p xml:id="_dvu6CgB"><s xml:id="_YJUZYwB">Participants in the group-incentive groups were also given a $200 bonus if they sustained abstinence through 6 months.</s><s xml:id="_m7fsu3h">Thus, the four interventions differed in how incentives would accrue and be disbursed (Fig. <ref type="figure" target="#fig_3">S2</ref> in the Supplementary Appendix), but the payment schedule and bonus were identical, and on the basis of anticipated success rates, we estimated that each intervention carried an expected value of $800.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SmcQuzB">Outcomes</head><p xml:id="_RQgw3jX"><s xml:id="_hM6C6Zv">The primary outcome was sustained abstinence from smoking for 6 months after the target quit date. <ref type="bibr" target="#b26">27</ref></s><s xml:id="_fZ8ayVz">Achievement of sustained abstinence required that submitted saliva samples had a cotinine concentration of less than 10 ng per milliliter 28 at 14 days, 30 days, and 6 months.</s><s xml:id="_NRE8qYF">For users of nicotine-replacement therapy, a urinary sample with an anabasine concentration of less than 3 ng per milliliter was considered to show sustained abstinence. <ref type="bibr" target="#b28">29</ref></s><s xml:id="_MmcXAgp">Participants who did not submit samples were coded as actively smoking.</s><s xml:id="_TVdnMGd">Secondary outcomes included the initial quit rate at 14 days, sustained abstinence for 30 days, and sustained abstinence through 12 months (i.e., 6 months after the final incentive disbursement).</s></p><p xml:id="_9HYgV7d"><s xml:id="_dW3RYNZ">Incentive acceptance rates reflected the proportion of participants assigned to that incentive who agreed to the contract.</s><s xml:id="_AsDK2xa">In the two groups requiring deposits, we considered participants to have accepted the intervention if they made $150 deposits by credit or debit card within 60 days after enrollment or before their selected quit date, whichever came first.</s><s xml:id="_QJzztYd">Consenting participants who declined their assigned program remained in their assigned group for intentionto-treat analyses and were treated identically to those in the usual-care group.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_MNZMx6y">Statistical Analysis</head><p xml:id="_HquzmRD"><s xml:id="_dEMXJJc">We specified three analyses corresponding to the aims of the study.</s><s xml:id="_qrnAXDj">First, we used logistic regression to compare acceptance of the interventions, adjusting for the two variables according to which the randomization was stratified. <ref type="bibr" target="#b29">30</ref></s><s xml:id="_rw97t2E">Second, we conducted intention-to-treat analyses using logistic regression to compare the effectiveness of incentive programs among all randomly assigned participants.</s><s xml:id="_tn4aDfB">Third, we compared the efficacy of the interventions.</s><s xml:id="_xYzjJPa">We first conducted traditional per-protocol analyses, comparing groups of participants who accepted different interventions.</s><s xml:id="_sRY2Bqp">However, because such analyses are subject to selection biases, <ref type="bibr" target="#b30">31</ref> our primary approach to measure efficacy modeled the randomization group as an instrumental variable <ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33</ref> in analyses of the complier average treatment effect. <ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref></s><s xml:id="_khQuQeP">5]<ref type="bibr" target="#b35">[36]</ref> These analyses, described in detail in the Supplementary Appendix, used data on all randomly assigned participants to estimate treatment effects for participants who would have accepted each intervention.</s></p><p xml:id="_SYZ6rnS"><s xml:id="_4PMehsj">We estimated that a sample of 2185 participants would provide 80% power to detect absolute differences of at least 7.5 percentage points in the rate of sustained abstinence between any one of the three novel incentive programs and the individual-reward program.</s><s xml:id="_vT3Va54">Details of this calculation are provided in the Supplementary Appendix.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EqCWyXd">R esult s</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_REXhhdS">Patient Characteristics</head><p xml:id="_WqmuRjB"><s xml:id="_JF4aRuV">Overall, 2538 participants were enrolled.</s><s xml:id="_JQkU6Fn">The demographic and smoking-related characteristics of the participants were balanced across the five study groups (Table <ref type="table">1</ref>).</s></p><p xml:id="_TmJmPyh"><s xml:id="_yJ6TXXC">Characteristic Usual Care (N = 468) Individual Reward (N = 498) Collaborative Reward (N = 519) Individual Deposit (N = 582) Competitive Deposit (N = 471) Demographic characteristics Age -yr Median 34 32 32 33 33 Interquartile range 26-47 25-46 25-45 25-48 25-45 Female sex -no.</s><s xml:id="_tgyXEnC">(%) 300 (64) 312 (63) 322 (62) 367 (63) 293 (62) Race -no.</s><s xml:id="_XjXrNCY">(%) † White 365 (78) 409 (82) 387 (75) 452 (78) 376 (80) Black 43 (9) 44 (9) 58 (11) 54 (9) 49 (10) Other 60 (13) 45 (9) 74 (14) 76 (13) 46 (10) Years of education ‡ Median 13 13 13 13 13 Interquartile range 12-14 12-14 12-15 12-15 12-15 Annual household income -no.</s><s xml:id="_XWKpKTN">(%) &lt;$60,000 346 (74) 375 (75) 382 (74) 403 (69) 358 (76) ≥$60,000 122 (26) 123 (25) 137 (26) 179 (31) 113 (24) Health insurance -no.</s><s xml:id="_hYKBN3M">(%) § CVS Caremark employee Enrolled in CVS Caremark health care plan 152 (32) 174 (35) 177 (34) 213 (37) 168 (36) Not enrolled in CVS Caremark health care plan 139 (30) 136 (27) 151 (29) 180 (31) 146 (31) Relative or friend of CVS Caremark employee Enrolled in CVS Caremark health care plan 36 (8) 33 (7) 26 (5) 29 (5) 36 (8) Not enrolled in CVS Caremark health care plan 141 (30) 155 (31) 165 (32) 160 (27) 121 (26) Smoking history No. of cigarettes smoked per day Median 15 15 15 15 15 Interquartile range 10-20 10-20 9-20 10-20 10-20 Duration of regular smoking -yr Median 15 12 13 14 14 Interquartile range 6-26 6-25 6-25 6-25 7-25 Age at first smoking -yr Median 17 17 17 17 17 Interquartile range 15-19 15-19 15-19 15-19 15-19 Level of nicotine dependence -no.</s><s xml:id="_KPejHAP">(%) ¶ Low 101 (22) 111 (22) 118 (23) 122 (21) 95 (20) Low to moderate 148 (32) 155 (31) 152 (29) 185 (32) 141 (30) Moderate 194 (41) 210 (42) 229 (44) 251 (43) 215 (46) High 25 (5) 22 (4) 20 (4) 24 (4) 20 (4) Stage of change -no.</s><s xml:id="_4qgR8FA">(%)‖ Preparation 300 (64) 312 (63) 327 (63) 372 (64) 312 (66) Contemplation 168 (36) 186 (37) 192 (37) 210 (36) 158 (34) Successfully quit for a 24-hr period in past year -no.</s><s xml:id="_u2xPgbj">(%) 300 (64) 307 (62) 328 (63) 361 (62) 294 (62) Table 1.</s><s xml:id="_bs9cm4t">Participant Characteristics (Intention-to-Treat Population).*</s><s xml:id="_DvanJ2K">The New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.</s><s xml:id="_UsF6kmY">Downloaded from nejm.org at University of Iowa--Iowa City on July 28, 2025.</s><s xml:id="_r6rw8W7">Copyright © 2015 Massachusetts Medical Society.</s><s xml:id="_59CQJXp">All rights reserved, including those for text and data mining, AI training, and similar technologies.</s><s xml:id="_nTh8GSy">n engl j med 372;22 nejm.org</s><s xml:id="_7UtcYFZ">May 28, 2015 2113 Financial-Incentive Progr ams for Smoking Cessation</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_McSHJ6d">Acceptance of Interventions</head><p xml:id="_mEJxK4V"><s xml:id="_EDEa8Cg">Of 2070 participants assigned to one of the four intervention groups, 1060 (51.2%) accepted that intervention.</s><s xml:id="_hupqqqq">Participants were much more likely to accept the two reward-based incentive programs (combined acceptance rate, 90.0%) than the two deposit-based programs (combined acceptance rate, 13.7%) (P&lt;0.001) (Fig. <ref type="figure" target="#fig_3">2</ref>).</s><s xml:id="_2ESKvZD">Participants were similarly likely to accept the individual incentives (combined acceptance rate, 50.6%) and the group incentives (combined acceptance rate, 51.9%) (P = 0.55).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2qpc77m">Effectiveness and Costs of Interventions</head><p xml:id="_rsYuuct"><s xml:id="_jTZknHn">Median payouts to participants who stopped smoking in the four incentive groups were similar (Table <ref type="table">S1</ref> in the Supplementary Appendix).</s><s xml:id="_gHtRmWh">In intention-to-treat analyses, all four programs yielded greater rates of sustained abstinence from smoking through 6 months (range, 9.4 to 16.0%) than did usual care (6.0%) (P&lt;0.05 for all comparisons) (Fig. <ref type="figure" target="#fig_5">3</ref>, and Table <ref type="table">S2</ref> in the Supplementary Appendix).</s><s xml:id="_bwwj7aN">At 12 months (6 months after the cessation of incentives), roughly half the participants who were abstinent through 6 months in all groups submitted negative cotinine assays, and only the reward-based incentive programs remained superior to usual care (Fig. <ref type="figure" target="#fig_5">3</ref>).</s><s xml:id="_AyBFQhb">The proportion of self-reported quitters who submitted a cotinine sample was lower at 12 months than at 30 days or 6 months in all groups (Table <ref type="table">S3</ref> in the Supplementary Appendix).</s><s xml:id="_aA7care">In secondary analyses of self-reported abstinence at 12 months, relapsed smoking was much less common than in analyses requiring biochemical confirmation, and all incentive groups remained superior to usual care (Table <ref type="table">S2</ref> in the Supplementary Appendix).</s></p><p xml:id="_AkBhZzD"><s xml:id="_ejNKX8V">At 6 months, the proportion of participants with sustained abstinence was greater with reward-based incentives (15.7%) than with depositbased incentives (10.2%) (P&lt;0.001)</s><s xml:id="_rwjtDqS">(Table <ref type="table">S4</ref> in the Supplementary Appendix) and was similar between participants assigned to individualincentive programs and those assigned to groupincentive programs (12.1% vs. 13.7%,</s><s xml:id="_f2xFHWh">P = 0.29) (Table <ref type="table">S5</ref> in the Supplementary Appendix).</s><s xml:id="_m66YFyB">Participants with access to free pharmacologic cessation aids through their CVS Caremark benefits did not have higher abstinence rates than participants without such benefits (Table <ref type="table">S6</ref> in the Supplementary Appendix).</s><s xml:id="_CWGxUfZ">Total costs spent per participant who had sustained abstinence were lower in the deposit-based groups than in the reward-based groups (Fig. <ref type="figure" target="#fig_5">S3</ref> in the Supplementary Appendix).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jhpaQFn">Efficacy of Interventions</head><p xml:id="_3Ex6srU"><s xml:id="_uwuRR57">Given the similar effectiveness of individual rewards and collaborative rewards and of individ- Currently using other methods to quit smoking -no.</s><s xml:id="_Hz9Mwaw">(%)** 65 ( <ref type="formula">14</ref>) 51 ( <ref type="formula">10</ref>) 71 ( <ref type="formula">14</ref>) 73 ( <ref type="formula">13</ref>) 47 (10)   * The intention-to-treat population includes all participants who underwent randomization to the five study groups.</s><s xml:id="_YzeFNTH">There were no significant differences between the study groups in any of the baseline characteristics listed (P&gt;0.05).</s><s xml:id="_wq9fVjz">NRT denotes nicotine-replacement therapy.</s><s xml:id="_Jage9RG">† Race was self-reported.</s><s xml:id="_zTWMs5C">‡ Years of education range from grade 1 to 17, with 17 representing "at least some graduate school" and 13 to 16 representing 1 to 4 years of college.</s><s xml:id="_5cXuPRN">§ The CVS Caremark health care plan includes free access to a behavioral-modification program and NRT.</s><s xml:id="_tvtnhtP">¶ The level of dependence is based on the score on the Fagerström Test for Nicotine Dependence.</s><s xml:id="_jurttdY">Scores range from 1 to 10, with higher scores indicating a more intense physical dependence on nicotine.</s><s xml:id="_vrUN8uX">Low dependence corresponds to a score of 1 or 2, low-to-moderate dependence a score of 3 or 4, moderate dependence a score of 5 to 7, and high dependence a score of 8 to 10. ‖ The participants were asked, "Are you seriously thinking of quitting smoking?" and were given three options to select: yes, within the next 30 days (preparation stage); yes, within the next 6 months (contemplation stage); or no, not thinking of quitting (precontemplation stage).</s><s xml:id="_SUpzGTm">The values for contemplation stage include 10 participants in the precontemplation stage: 2 participants in the usual-care group, 2 participants in the individual-reward group, 2 participants in the collaborative-reward group, 3 participants in the individual-deposit group, and 1 participant in the competitive-deposit group.</s><s xml:id="_eu3ASYs">Data were missing for 1 participant in the competitive-deposit group.</s><s xml:id="_hSGv5EU">** Participant is currently using NRT, behavioral therapy, prescription medication, or other method to quit smoking.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_wSM2JVH">Table 1. (Continued.)</head><p xml:id="_4sQbdpt"><s xml:id="_cEprAmY">The New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.</s><s xml:id="_YW4hcxu">ual deposits and competitive deposits, we grouped the reward-based incentives as well as the deposit-based incentives for efficacy analyses.</s><s xml:id="_tuEsHZE">In standard per-protocol analyses, 52.3% of those who accepted deposits versus 17.1% of those who accepted rewards had sustained abstinence through 6 months (P&lt;0.001), and similarly large differences were observed at all time points (Table <ref type="table">S7</ref> in the Supplementary Appendix).</s><s xml:id="_wFsemFM">In analyses of the complier average treatment effect, which adjust for the selection effects inherent in per-protocol analyses, the rate of abstinence at 6 months was 13.2 percentage points (95% confidence interval, 3.1 to 22.8) higher in the deposit-based programs than in the reward-based programs among the 13.7% of smokers who would accept either type of incentive (Table <ref type="table">2</ref>).</s><s xml:id="_BzErb49">According to this approach, deposits were superior to rewards even if we assumed that participants who would accept deposits had up to 12.5 times greater underlying propensities to stop smoking than participants who would accept rewards only.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_DTnJQ3h">Analyses Accounting for Enrollment of Potential Nonsmokers</head><p xml:id="_XdmHQrE"><s xml:id="_JdJ4YcK">Among 150 participants asked to submit a cotinine assay at baseline to confirm smoking status, 9 (6.0%) submitted negative assays and 21 (14.0%) did not return assays.</s><s xml:id="_mePc2Tw">These rates were similar across groups (Table <ref type="table">S8</ref> in the Supplementary Appendix), and sensitivity analyses adjusting for the possibility that up to 20% of the participants were not smokers revealed nearly identical estimates of effectiveness (Table <ref type="table">S9</ref> in the Supplementary Appendix).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_nsyrRb9">Discussion</head><p xml:id="_9qsG9BF"><s xml:id="_QwZGYkK">More than 50 years after the release of the first Surgeon General's report on the harmful effects of smoking, national policies, behavioral programs, and pharmacologic approaches have helped reduce smoking rates in the United States. <ref type="bibr" target="#b36">37</ref></s><s xml:id="_eHWbWXX">owever, the need for new approaches is clear because smoking remains the leading cause of preventable illness and death. <ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b38">39</ref></s><s xml:id="_Cjwn4A4">n this large randomized trial across the United States, we found that four different incentive programs with expected values of $800 were each effective in promoting sustained abstinence from smoking.</s><s xml:id="_usg5NmJ">Perhaps the most important finding is that incentive programs that required people to deposit $150 of their own money were less effective overall than rewardbased programs of similar value because few people accepted such deposit programs.</s><s xml:id="_QXEdrjY">This was true despite the $650 reward offered to depositarm participants in addition to the return of their original $150 deposits.</s><s xml:id="_9QA3Jnq">However, analyses that account for the different acceptance rates of the interventions showed that deposit-based incentives were substantially more efficacious than reward-based incentives among people who would have accepted either.</s><s xml:id="_mRntHXz">The robustness of this result to reasonably large potential selection effects suggests that incentives that build on participants' loss aversion <ref type="bibr" target="#b12">13</ref> may meaningfully change behavior.</s></p><p xml:id="_jQsnRh3"><s xml:id="_vJG3eYe">Second, we found that group-oriented reward programs were not significantly more effective than individual-oriented programs.</s><s xml:id="_SEcNkgt">The results of this large trial are therefore consistent with those of small randomized, controlled trials of incentives for weight loss in which group-oriented Acceptance rates were adjusted for two stratifying variables <ref type="bibr" target="#b29">30</ref> : whether participants received their health insurance through CVS Caremark and whether their annual household income was at least $60,000 or less than $60,000.</s><s xml:id="_7T6sQuR">I bars denote 95% confidence intervals.</s><s xml:id="_AY6rdxJ">In parentheses, the numerator indicates the number of participants accepting each intervention, and the denominator indicates the number of participants assigned to each intervention.</s><s xml:id="_HbpGdfX">The usual-care group is not shown, because there was no option to decline usual care.</s></p><p xml:id="_EKMPPbj"><s xml:id="_dz7JFFZ">Acceptance of Assigned Intervention (%) 100 80 90 70 60 40 30 10 50 20 0 Assigned Intervention Individual reward (472/498)</s></p><p xml:id="_vVt6DPa"><s xml:id="_XRXuf66">Collaborative reward (442/519) Individual deposit (75/582) Competitive deposit (71/471) 94.8 85.3 12.6 15.1 The New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.</s><s xml:id="_2yARNxm">Downloaded from nejm.org at University of Iowa--Iowa City on July 28, 2025.</s><s xml:id="_A5FzbAM">Copyright © 2015 Massachusetts Medical Society.</s><s xml:id="_aUqDNHZ">All rights reserved, including those for text and data mining, AI training, and similar technologies.</s><s xml:id="_Dy79qEX">n engl j med 372;22 nejm.org</s><s xml:id="_JfQFzvt">May 28, 2015 2115 Financial-Incentive Progr ams for Smoking Cessation</s></p><p xml:id="_nSKZ295"><s xml:id="_EFMcwPh">payments, as compared with individual-oriented payments, produced small early benefits that were not sustained over time. <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b21">22</ref></s><s xml:id="_ASDCM72">inally, the finding that individual rewards of $800, as compared with usual care, nearly tripled the rate of smoking cessation among CVS Caremark employees and their friends and family confirms and extends the generalizability of our finding from a previous trial involving General Electric employees. <ref type="bibr" target="#b7">8</ref></s><s xml:id="_srVhjsJ">In addition to the public health effects of such smoking reductions, these findings are important for employers.</s><s xml:id="_kbgnAUu">Because employing a smoker is estimated to cost $5,816 more each year than employing a nonsmoker, <ref type="bibr" target="#b39">40</ref> even an $800 payment borne entirely by employers and paid only to those who quit would be highly cost-saving.</s></p><p xml:id="_HgXdwuV"><s xml:id="_Uw6kp6w">This study has limitations.</s><s xml:id="_VTnASTR">First, the low rate of acceptance of the deposit programs required protocol modifications to restrict the proportions of participants who would be randomly assigned to those groups.</s><s xml:id="_EyeCyf3">Implementing these limitations preserved balance in participant characteristics across groups and preserved power for all effectiveness analyses but limited the precision of analyses comparing the efficacy of reward and deposit groups.</s><s xml:id="_wYhgQBe">Second, only 41% of the participants had access to free pharmacologic and behavioral cessation aids through their employee benefits.</s><s xml:id="_5zCee4X">However, smoking-cessation rates were not higher among those with access to such aids, a finding that suggests that the superiority of incentives would hold in populations with universal access.</s><s xml:id="_tKZcXe6">Third, in all trial groups, nearly half the smokers who quit at the end of the intervention at 6 months did not document sustained abstinence through 12 months.</s><s xml:id="_hceyB3h">This suggests similar durability of financial incentives to nicotine-replacement therapy and bupropion, for which relapse after completion of treatment has also occurred in roughly 50% of the participants. <ref type="bibr" target="#b40">41,</ref><ref type="bibr" target="#b41">42</ref></s><s xml:id="_3xck7QR">Secondary analyses suggest that the true relapse rates in our trial may have been lower, given the reduction in submission of any samples at 12 months across groups (Table <ref type="table">S3</ref> in the Supplementary Appendix).</s></p><p xml:id="_vgw7bXg"><s xml:id="_EFDMhKz">This study also has several strengths.</s><s xml:id="_Gv3AhXN">In addition to comparing financial incentives for smoking cessation in a large number of partici-pants, the trial measured the specific contributions of acceptance and efficacy of the interventions to their overall effectiveness.</s><s xml:id="_rfJgUfw">This trial also compared multiple incentive programs with design features based on behavioral economic theory, including repeated payments to reinforce target behaviors, <ref type="bibr" target="#b42">43</ref> bonus payments at the end of the intervention to offset smokers' tendencies to discount the importance of future events, <ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b44">45</ref> and the provision of ongoing feedback regarding participants' accrued gains and losses contingent on their self-reported smoking status to maximize the effect of regret aversion. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21</ref></s><s xml:id="_YaZwGmT">Finally, this trial randomly selected participants for screening cotinine tests to prevent nonsmokers from enrolling.</s><s xml:id="_MbD4W8n">The robustness of our findings in analyses accounting for potential participation of nonsmokers provides strong evidence regarding the effectiveness of incentives.</s><s xml:id="_Njy8ZnX">Sustained Abstinence (% of participants) 20 10 15 5 0 6 12 Months from Selected Quit Date Usual care Individual reward Collaborative reward Individual deposit Competitive deposit Randomization Group *** *** * ** ** ** The New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.</s><s xml:id="_mJEeTHe">Downloaded from nejm.org at University of Iowa--Iowa City on July 28, 2025.</s><s xml:id="_qb6h6Pg">Copyright © 2015 Massachusetts Medical Society.</s><s xml:id="_x3PxXs8">All rights reserved, including those for text and data mining, AI training, and similar technologies.</s></p><p xml:id="_hBDMaFp"><s xml:id="_XqvgxWm">In summary, this trial shows that among several financial-incentive programs for smoking cessation, rewards for smoking cessation are more effective overall than are deposit-based contracts owing to their much higher rate of acceptance.</s><s xml:id="_kRRNeG3">In addition, the efficacy of depositbased contracts among those who use them and the cost-effectiveness of such contracts for employers suggest that future innovations in em-ployee benefit design should seek to establish the effectiveness of smoking-cessation programs requiring deposits smaller than the $150 used in this trial.</s></p><p xml:id="_6s4W8gq"><s xml:id="_E7sMnKX">Supported by a grant from the National Cancer Institute (R01 CA159932, to Dr. Halpern), a grant from the National Institute on Aging (RC2 AG036592, to Drs.</s><s xml:id="_qxNRkaM">Asch and Volpp), and CVS Caremark.</s></p><p xml:id="_gQUwBet"><s xml:id="_jMdRHvn">Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_AUQRNV8"><s xml:id="_3AMaeMa">Figure 1.</s><s xml:id="_yMMCbJM">Assessment for Eligibility and Randomization.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><figDesc><div><p xml:id="_uffDdrf"><s xml:id="_xY8yYqj">Ever used NRT or assistance to quit smoking -no.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><figDesc><div><p xml:id="_QScKTW3"><s xml:id="_5hND5B6">Downloaded from nejm.org at University of Iowa--Iowa City on July 28, 2025.</s><s xml:id="_BeHBJmp">Copyright © 2015 Massachusetts Medical Society.</s><s xml:id="_9FXSjtz">All rights reserved, including those for text and data mining, AI training, and similar technologies.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_vJeufk5"><s xml:id="_4Z9EXPa">Figure 2. Acceptance Rates of Financial-Incentive Structures.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 3 .</head><label>3</label><figDesc><div><p xml:id="_cdVaCT4"><s xml:id="_x6Czrz2">Figure 3.</s><s xml:id="_YEFdMSM">Rates of Sustained Abstinence from Smoking at 6 and 12 Months after Target Quit Date.The primary outcome was sustained abstinence through 6 months.</s><s xml:id="_ArG3G9h">Asterisks indicate P values (* for P&lt;0.05, ** for P&lt;0.01, and *** for P&lt;0.001) for the comparison of the four intervention groups to usual care, with adjustment for the two stratifying variables<ref type="bibr" target="#b29">30</ref> : whether participants received their health insurance through CVS Caremark and whether their annual household income was at least $60,000 or less than $60,000.</s><s xml:id="_3DApjYH">I bars indicate 95% confidence intervals.</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_xmAeNFe"><s xml:id="_5zP92Fz">The New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.</s><s xml:id="_FKqGTWF">Downloaded from nejm.org at University of Iowa--Iowa City on July 28, 2025.</s><s xml:id="_KP66n92">Copyright © 2015 Massachusetts Medical Society.</s><s xml:id="_c6kAhMN">All rights reserved, including those for text and data mining, AI training, and similar technologies.</s><s xml:id="_vUK3KXg">n engl j med 372;22 nejm.org</s><s xml:id="_B4w5QZp">May 28, 2015</s></p></note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_u4YjCpc">Comparison of Efficacy</head><note type="other" xml:id="_AAWEtJW">Absolute</note><p xml:id="_r5N65nD"><s xml:id="_39ZAjDm">* A detailed explanation of this analysis is provided in the Supplementary Appendix.</s><s xml:id="_6KsScHh">In brief, this method uses the randomization group as an instrumental variable, thereby providing estimates of the efficacy of interventions among people who accept them.</s><s xml:id="_XVQjwYp">Unlike traditional per-protocol analyses, this approach uses data on all randomly assigned participants and adjusts estimates of efficacy for the selection biases that may arise if participants' decisions to accept or decline their assigned interventions are related to their underlying odds of smoking cessation. <ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref></s><s xml:id="_gU3XeBv">5]<ref type="bibr" target="#b35">[36]</ref> This analysis assumes that participants who would accept deposits would have also accepted rewards if rewards had instead been offered.</s></p><p xml:id="_XkScDdX"><s xml:id="_UUWRUBu">Estimates are on the additive scale; thus, absolute risk differences are shown with 95% confidence intervals (CIs).</s><s xml:id="_pxgAH64">† The efficacy of deposit contracts is statistically superior to the efficacy of rewards as long as the underlying odds of quitting among participants who accept deposits are no more than 12.5 times greater than the odds of quitting among participants who would only accept rewards.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_W6rj54g">Incentives improve outcome in outpatient behavioral treatment of cocaine dependence</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Budney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Bickel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Foerg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Donham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Badger</surname></persName>
		</author>
		<idno type="DOI">10.1001/archpsyc.1994.03950070060011</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YsYP2vD">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="568" to="576" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. Incen- tives improve outcome in outpatient be- havioral treatment of cocaine dependence. Arch Gen Psychiatry 1994; 51: 568-76.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_geVXsdK">A structured review of the effect of economic incentives on consumers&apos; preventive behavior</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Kane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Town</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Butler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ezvMchb">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="327" to="352" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kane RL, Johnson PE, Town RJ, Butler M. A structured review of the effect of economic incentives on consumers&apos; pre- ventive behavior. Am J Prev Med 2004; 27: 327-52.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_yHw2zDx">A meta-analysis of voucher-based reinforcement therapy for substance use disorders</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Lussier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Heil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Mongeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Badger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Higgins</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1360-0443.2006.01311.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cp6rM4H">Addiction</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="192" to="203" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lussier JP, Heil SH, Mongeon JA, Bad- ger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006; 101: 192-203.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_vqt2GTK">Financial incentive-based approaches for weight loss: a randomized trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>John</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Troxel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Norton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fassbender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Loewenstein</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2008.804</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gU2fCSJ">JAMA</title>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="page" from="2631" to="2637" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA 2008; 300: 2631-7.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_MuNbMEu">A test of financial incentives to improve warfarin adherence</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Loewenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Troxel</surname></persName>
		</author>
		<idno type="DOI">10.1186/1472-6963-8-272</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wUWHXQh">BMC Health Serv Res</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">272</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Volpp KG, Loewenstein G, Troxel AB, et al. A test of financial incentives to im- prove warfarin adherence. BMC Health Serv Res 2008; 8: 272.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_X75R8wJ">Should we pay the patient? Review of financial incentives to enhance patient compliance</title>
		<author>
			<persName><forename type="first">A</forename><surname>Giuffrida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Torgerson</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.315.7110.703</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Pw2Qdce">BMJ</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="page" from="703" to="707" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Giuffrida A, Torgerson DJ. Should we pay the patient? Review of financial in- centives to enhance patient compliance. BMJ 1997; 315: 703-7.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_9G5STXY">Impact of targeted financial incentives on personal health behavior: a review of the literature</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sutherland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Christianson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Leatherman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2Y2MzBM">Med Care Res Rev</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="36S" to="78S" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
	<note type="raw_reference">Sutherland K, Christianson JB, Leather- man S. Impact of targeted financial incen- tives on personal health behavior: a review of the literature. Med Care Res Rev 2008; 65: Suppl: 36S-78S.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_u5AJjNx">A randomized, controlled trial of financial incentives for smoking cessation</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Troxel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Pauly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rtEC4T4">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="page" from="699" to="709" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Volpp KG, Troxel AB, Pauly MV, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009; 360: 699-709.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_HQA8kxG">Reward-based incentives for smoking cessation: how a carrot became a stick</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Galvin</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2014.418</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rTfNphT">JAMA</title>
		<imprint>
			<biblScope unit="volume">311</biblScope>
			<biblScope unit="page" from="909" to="910" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Volpp KG, Galvin R. Reward-based incentives for smoking cessation: how a carrot became a stick. JAMA 2014; 311: 909-10.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_3tSvyvp">Does it work to pay peo-ple to live healthier lives?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Strickland</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.g2458</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AwhvmSe">BMJ</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="page">2458</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Strickland S. Does it work to pay peo- ple to live healthier lives? BMJ 2014; 348: g2458.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<ptr target="http://www.towerswatson.com/en-US/Insights/IC-Types/Survey-Research-Results/2014/05/full-report-towers-watson-nbgh-2013-2014-employer-survey-on-purchasing-value-in-health-care" />
		<title level="m" xml:id="_qhRer78">Employer survey on purchasing value in health care</title>
		<imprint>
			<publisher>Towers Watson National Business Group on Health</publisher>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Towers Watson National Business Group on Health. Employer survey on purchasing value in health care, 2014 (http://www .towerswatson .com/ en-US/ Insights/ IC-Types/ Survey-Research-Results/ 2014/ 05/ full-report-towers-watson-nbgh -2013-2014-employer-survey-on-purchasing -value-in-health-care).</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_xDT3gUF">P4P4P: an agenda for research on pay-for-performance for patients</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Pauly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Loewenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bangsberg</surname></persName>
		</author>
		<idno type="DOI">10.1377/hlthaff.28.1.206</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dbdwC2C">Health Aff (Millwood)</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="206" to="214" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Volpp KG, Pauly MV, Loewenstein G, Bangsberg D. P4P4P: an agenda for research on pay-for-performance for patients. Health Aff (Millwood) 2009; 28: 206-14.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_ekZHZSe">Prospect theory: an analysis of decision under risk</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kahneman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tversky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Hz2YZK3">Econometrica</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="263" to="291" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica 1979; 47: 263-91.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_HJmPH6z">Commitment contracts as a way to health</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Halpern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.e522</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YkDa27E">BMJ</title>
		<imprint>
			<biblScope unit="volume">344</biblScope>
			<biblScope unit="page">e522</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Halpern SD, Asch DA, Volpp KG. Commitment contracts as a way to health. BMJ 2012; 344: e522.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_Dxmp8zG">Financial-Incentive Progr ams for Smoking Cessation Commitment devices: using initiatives to change behavior</title>
		<author>
			<persName><forename type="first">T</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Milkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2014.3485</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dFcD7fq">JAMA</title>
		<imprint>
			<biblScope unit="volume">311</biblScope>
			<biblScope unit="page" from="2065" to="2066" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rogers T, Milkman KL, Volpp KG. Financial-Incentive Progr ams for Smoking Cessation Commitment devices: using initiatives to change behavior. JAMA 2014; 311: 2065-6.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_hW4MTRq">The collective dynamics of smoking in a large social network</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Christakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Fowler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uZgjpsN">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">358</biblScope>
			<biblScope unit="page" from="2249" to="2258" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Christakis NA, Fowler JH. The collec- tive dynamics of smoking in a large social network. N Engl J Med 2008; 358: 2249-58.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_73Nr97m">Collective dynamics of &apos;small-world&apos; networks</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Watts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Strogatz</surname></persName>
		</author>
		<idno type="DOI">10.1038/30918</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gSwGHaX">Nature</title>
		<imprint>
			<biblScope unit="volume">393</biblScope>
			<biblScope unit="page" from="440" to="442" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Watts DJ, Strogatz SH. Collective dy- namics of &apos;small-world&apos; networks. Nature 1998; 393: 440-2.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_FN7XcSj">A systematic review of the effectiveness of group versus individual treatments for adult obesity</title>
		<author>
			<persName><forename type="first">V</forename><surname>Paul-Ebhonhimhen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Avenell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_J3AUvXE">Obes Facts</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="17" to="24" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Paul-Ebhonhimhen V, Avenell A. A sys- tematic review of the effectiveness of group versus individual treatments for adult obesity. Obes Facts 2009; 2: 17-24.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_RV6kXpK">Monetary contracts in weight control: effectiveness of group and individual contracts of varying size</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Jeffery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Gerber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Rosenthal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Lindquist</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Pz5ER5z">J Consult Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="242" to="248" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jeffery RW, Gerber WM, Rosenthal BS, Lindquist RA. Monetary contracts in weight control: effectiveness of group and individual contracts of varying size. J Con- sult Clin Psychol 1983; 51: 242-8.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_Cm9hZv4">Regret in economic and psychological theories of choice</title>
		<author>
			<persName><forename type="first">T</forename><surname>Connolly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">U</forename><surname>Butler</surname></persName>
		</author>
		<idno type="DOI">10.1002/bdm.510</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UYjxpJd">J Behav Decis Mak</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="148" to="158" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Connolly T, Butler DU. Regret in eco- nomic and psychological theories of choice. J Behav Decis Mak 2006; 19: 148-58.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_uFpvg9W">Wearing out your shoes to prevent someone else from stepping into them: anticipated regret and social takeover in sequential decisions</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hoelzl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Loewenstein</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.obhdp.2005.04.004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8n3VsNe">Organ Behav Hum Decis Process</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="15" to="27" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hoelzl E, Loewenstein G. Wearing out your shoes to prevent someone else from stepping into them: anticipated regret and social takeover in sequential deci- sions. Organ Behav Hum Decis Process 2005; 98: 15-27.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_EBZXBGn">Individual-versus group-based financial incentives for weight loss: a randomized, controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Kullgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Troxel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Loewenstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GfXBZwV">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="505" to="514" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kullgren JT, Troxel AB, Loewenstein G, et al. Individual-versus group-based financial incentives for weight loss: a ran- domized, controlled trial. Ann Intern Med 2013; 158: 505-14.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_qW4XKcA">Efficient randomized-adaptive designs</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">F</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">M</forename><surname>He</surname></persName>
		</author>
		<idno type="DOI">10.1214/08-aos655</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XC3VNtM">Ann Statist</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="2543" to="2560" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hu FF, Zhang LX, He XM. Efficient randomized-adaptive designs. Ann Statist 2009; 37: 2543-60.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_v3WJ4kk">Adaptive designs: terminology and classification</title>
		<author>
			<persName><forename type="first">V</forename><surname>Dragalin</surname></persName>
		</author>
		<idno type="DOI">10.1177/216847900604000408</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ngXAehb">Drug Inf J</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="425" to="435" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dragalin V. Adaptive designs: termi- nology and classification. Drug Inf J 2006; 40: 425-35.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_zZMjpB7">Adaptive designs for randomized trials in public health</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ten</forename><surname>Have</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Jo</forename><forename type="middle">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7wXx7ap">Annu Rev Public Health</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1" to="25" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brown CH, Ten Have TR, Jo B, et al. Adaptive designs for randomized trials in public health. Annu Rev Public Health 2009; 30: 1-25.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_kxqBEAq">Preference-adaptive randomization in comparative effectiveness studies</title>
		<author>
			<persName><forename type="first">B</forename><surname>French</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Novak</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13063-015-0592-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gbtUxJS">Trials</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">99</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">French B, Small DS, Novak J, et al. Preference-adaptive randomization in com- parative effectiveness studies. Trials 2015; 16: 99.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_w9BFQjJ">Measures of abstinence in clinical trials: issues and recommendations</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Keely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Niaura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Ossip-Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Richmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Swan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cUxyzbF">Nicotine Tob Res</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="13" to="25" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hughes JR, Keely JP, Niaura RS, Ossip- Klein DJ, Richmond RL, Swan GE. Mea- sures of abstinence in clinical trials: is- sues and recommendations. Nicotine Tob Res 2003; 5: 13-25.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_azxDtCG">Biochemical verification of tobacco use and cessation</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Benowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ahijevch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hall</surname></persName>
		</author>
		<idno type="DOI">10.1080/14622200210123581</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CK6zXbd">Nicotine Tob Res</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="149" to="159" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Benowitz NL, Ahijevch K, Hall S, et al. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4: 149-59.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_385Vqwu">Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy</title>
		<author>
			<persName><forename type="first">P</forename><surname>Jacob</surname></persName>
		</author>
		<author>
			<persName><surname>Iii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hatsukami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Severson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Benowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fWDSmhg">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1668" to="1673" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jacob P III, Hatsukami D, Severson H, Hall S, Yu L, Benowitz NL. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 2002; 11: 1668-73.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_Yg6MG3K">Improper analysis of trials randomised using stratified blocks or minimisation</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Kahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Morris</surname></persName>
		</author>
		<idno type="DOI">10.1002/sim.4431</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qwtCPxH">Stat Med</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="328" to="340" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kahan BC, Morris TP. Improper anal- ysis of trials randomised using stratified blocks or minimisation. Stat Med 2012; 31: 328-40.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_SaahzZm">On estimating efficacy from clinical trials</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sommer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Zeger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CeQRXqm">Stat Med</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="45" to="52" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sommer A, Zeger SL. On estimating efficacy from clinical trials. Stat Med 1991; 10: 45-52.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_zGDn3cy">Econometrics in outcomes research: the use of instrumental variables</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Newhouse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mcclellan</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev.publhealth.19.1.17</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xmGsSy2">Annu Rev Public Health</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="17" to="34" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Newhouse JP, McClellan M. Econo- metrics in outcomes research: the use of instrumental variables. Annu Rev Public Health 1998; 19: 17-34.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_EeqjruY">Identification of causal effects using instrumental variables</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Angrist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Imbens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rubin</forename><surname>Db</surname></persName>
		</author>
		<idno type="DOI">10.3386/t0136</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GeYQxD6">J Am Stat Assoc</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="444" to="455" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using in- strumental variables. J Am Stat Assoc 1996; 91: 444-55.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_gqP5fNd">An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Sussman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Hayward</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.c2073</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ktTSArW">BMJ</title>
		<imprint>
			<biblScope unit="volume">340</biblScope>
			<biblScope unit="page">2073</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sussman JB, Hayward RA. An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ 2010; 340: c2073.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_aF7MNQb">Bounds on causal effects in three-arm trials with noncompliance</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Small</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1467-9868.2006.00568.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DDqgyXg">J R Stat Soc B</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="815" to="836" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cheng J, Small D. Bounds on causal effects in three-arm trials with noncom- pliance. J R Stat Soc B 2006; 68: 815-36.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_grFNDr6">Efficient nonparametric estimation of causal effects in randomized trials with noncompliance</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ten</forename><surname>Have</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
		<idno type="DOI">10.1093/biomet/asn056</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uEMsFXN">Biometrika</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="19" to="36" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cheng J, Small D, Tan Z, Ten Have T. Efficient nonparametric estimation of causal effects in randomized trials with noncompliance. Biometrika 2009; 96: 19- 36.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<monogr>
		<ptr target="http://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf" />
		<title level="m" xml:id="_Kret2wY">The health consequences of smoking -50 years of progress: a report of the Surgeon General</title>
		<meeting><address><addrLine>Atlanta</addrLine></address></meeting>
		<imprint>
			<publisher>Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health</publisher>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">The health consequences of smoking -50 years of progress: a report of the Surgeon General. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014 (http://www .surgeongeneral .gov/ library/ reports/ 50-years-of-progress/ full-report .pdf).</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_kFEYV5n">Estimation of cigarette smoking-attributable morbidity in the United States</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Rostron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Pechacek</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2014.5219</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BdryzbV">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="page" from="1922" to="1928" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rostron BL, Chang CM, Pechacek TF. Estimation of cigarette smoking-attribut- able morbidity in the United States. JAMA Intern Med 2014; 174: 1922-8.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_Z6eTPN2">The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors</title>
		<author>
			<persName><forename type="first">G</forename><surname>Danaei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mozaffarian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CUV587K">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">1000058</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk fac- tors. PLoS Med 2009; 6(4): e1000058.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_VZa6fmv">Estimating the cost of a smoking employee</title>
		<author>
			<persName><forename type="first">M</forename><surname>Berman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Crane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Seiber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Munur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_P69gqm4">Tob Control</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="428" to="433" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Berman M, Crane R, Seiber E, Munur M. Estimating the cost of a smoking em- ployee. Tob Control 2014; 23: 428-33.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_mUS3Uah">A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Jorenby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Leischow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Nides</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejm199903043400903</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_T3MEYz3">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">340</biblScope>
			<biblScope unit="page" from="685" to="691" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-91.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_VhmnNFr">Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Schnoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Patterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Wileyto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FPGZ9Fu">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="144" to="151" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schnoll RA, Patterson F, Wileyto EP, et al. Effectiveness of extended-duration transdermal nicotine therapy: a random- ized trial. Ann Intern Med 2010; 152: 144- 51.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_uq8eMj8">Give them prizes, and they will come: contingency management for treatment of alcohol dependence</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Petry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Cooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Kranzler</surname></persName>
		</author>
		<idno type="DOI">10.1037//0022-006x.68.2.250</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SKJnhHm">J Consult Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="250" to="257" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Petry NM, Martin B, Cooney JL, Kran- zler HR. Give them prizes, and they will come: contingency management for treat- ment of alcohol dependence. J Consult Clin Psychol 2000; 68: 250-7.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_DBCMc54">Behavioral consequences of corporate incentives and long-term bonuses -an experimental study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Schotter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Weigelt</surname></persName>
		</author>
		<idno type="DOI">10.1287/mnsc.38.9.1280</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gNkVbnt">Manage Sci</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1280" to="1298" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schotter A, Weigelt K. Behavioral con- sequences of corporate incentives and long-term bonuses -an experimental study. Manage Sci 1992; 38: 1280-98.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_WBrehqb">Does delay discounting play an etiological role in smoking or is it a consequence of smoking?</title>
		<author>
			<persName><forename type="first">J</forename><surname>Audrain-Mcgovern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Epstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cuevas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Wileyto</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drugalcdep.2008.12.019</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8C6EDX2">Drug Alcohol Depend</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="99" to="106" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Audrain-McGovern J, Rodriguez D, Epstein LH, Cuevas J, Rodgers K, Wileyto EP. Does delay discounting play an etio- logical role in smoking or is it a conse- quence of smoking? Drug Alcohol Depend 2009; 103: 99-106.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
